"Designing Growth Strategies is in our DNA"

CAR-T Cell Therapy Market Size, Share & Industry Analysis, By Drug Type (Axicabtagene Ciloleucel (Yescarta), Brexucabtagene Autoleucel (Tecartus), Ciltacabtagene Autoleucel (Carvykti), Idecabtagene Vicleucel (Abecma), Lisocabtagene Maraleucel (Breyanzi), Tisagenlecleucel (Kymriah), and Others), By Indication (Acute Lymphoblastic Leukemia, Non-Hodgkin Lymphoma, and Multiple Myeloma), By End-user (Hospitals and Oncology Treatment Centers), and Regional Forecast, 2024-2032

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI108455

 


CAR-T Cell Therapy Market

  • 2019-2032
  • 2023
  • 2019-2022
  • 149
Consulting Services
    How will you benefit from our consulting services ?